Don’t miss the Europe H1 2023 Key Trends in Digital Health with this semi-annual report on the current state and future outlook of the global Digital Health ecosystem. As Europe jumps into second place for venture funding in Digital Health, it has already established itself as a focused and mature ecosystem, capturing the top spot globally for ventures with Clinical Evidence.
The Europe H1 2023 Key Trends report focuses on private ventures and includes current trends, ecosystem development, most active partners, and venture funding.
The “Europe Digital Health Innovation Ecosystem Report on H1 2023 Key Trends” report includes data on the following companies: Baseimmune, Doctorly, Alba Health, Gleamer, Phlo, Roche, AstraZeneca, Novartis, Pfizer, Cyted, Nye Health, SOPHiA GENETICS, BenevolentAI, Alex Therapeutics, Volta Medical, Distalmotion, Alentis Therapeutics, Patient21, Peppy, Caristo Diagnostics, Memodio, Perspectum Diagnostics, EBAMed, Skin + Me, Deeplink Medical, Dxcover, Nelly, InFlow, Haystack Oncology, Diamond Whites, Maela, UgenTec, Blackford Analytics, Bayer AG, Nouveal, Jefferson Health, Ada Health, RetinAI Medical, AIG, MediQuo, Gaia, Chugai Pharmaceutical
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
|ABOUT GALEN GROWTH|
|HEADLINES: 10 pages, 6 charts, 5 tables|
|ECOSYSTEM INSIGHTS: 5 pages, 8 charts, 5 tables|
|INVESTMENT INSIGHTS: 7 pages, 7 charts, 1 table|
|CLUSTER FOCUS: 4 pages, 2 charts, 1 table|
|THERAPEUTIC FOCUS: 3 pages, 2 charts, 1 table|
|DEEP DIVES: 21 pages, 24 charts, 4 tables|
|NOTEWORTHY: 4 pages, 3 tables|
© Galen Growth 2023